The landscape of diabetic management is rapidly evolving, and stem cell approaches are emerging as a remarkably intriguing area of study. While existing protocols often focus on controlling blood glucose levels and addressing secondary issues, stem cell therapy holds the potential to correct the underlying origins of Type-2 diabetic conditions. Sci